Type 1 Diabetes Trial, Recruiting NCT06282055 Sponsor: DCB Research AG Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT06282055
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are female
  • People who are between 18 and 40 years old at the time of joining
  • People who had their first period at least one year before joining the trial
  • People who have had at least one menstrual period in the last 40 days
  • People whose menstrual cycles are typically between 21 and 38 days long
  • People whose cycle length does not vary by more than 7 days between consecutive cycles
  • People who have been living with type 1 diabetes or a related condition called latent autoimmune diabetes in adults (LADA) for at least one year
  • People who have been using an automated insulin delivery (AID) system to manage their diabetes for at least six months before joining

Who may not be able to join:

  • People who regularly take hormonal medications (such as corticosteroids), with the exception of insulin, stable thyroid hormone replacement, and hormonal contraception
  • People who are currently pregnant, planning to become pregnant, or are within two months of giving birth
  • People who are currently breastfeeding or pumping, or who have stopped within the last two months
  • People who have been diagnosed with Polycystic Ovary Syndrome (PCOS)
  • People who are taking certain medications, including glucocorticoids, drugs that affect how quickly the stomach empties, Metformin, SGLT-2 inhibitors, or GLP-1 medications (confirm with trial site if unsure whether a current medication falls into these categories)
  • People who regularly work rotating night and day shifts (for example, switching between night and day shifts on a weekly basis)
  • People who have taken part in another interventional research study in the two months before joining, or who are currently participating in one

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +41794217376

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
DCB Research AG
Registry
ClinicalTrials.gov
Start date
20 November 2025
Est. completion
15 September 2027

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Identify clusters in trajectories across the menstrual cycle

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov